Background: Gangliocytic paraganglioma of the duodenum is a peculiar neuroendocrine tumor, often revealed as an incidental radiographic finding or as a result of gastrointestinal hemorrhage, due to frequent ulceration of the overlying mucosa. Most lesions are pedunculated and submucosal with distinctive histology, consisting of endocrine, ganglion and spindle-shaped Schwann cells. Methods: A case of a duodenal gangliocytic paraganglioma is reported in a 50-year-old woman presenting with episodes of melena. Enteroclysis revealed a pedunculated tumor observed either in the second or third portion of the duodenum. Upper gastrointestinal endoscopy revealed a pedunculated ulcerated tumor which was subsequently confirmed by computed tomography. The tumor was simply excised through a duodenotomy. Results: The size of the tumor was 4.5 × 3 × 1.5 cm. Immunohistochemical and ultrastructural features of the tumor classified it as a typical duodenal gangliocytic paraganglioma with positive cellular reaction for neuron-specific enolase, chromogranin, somatostatin, gastrin and S100. Conclusion: Forty-six months after surgery, the patient is well with no evidence of recurrence. The majority of the reported duodenal gangliocytic paragangliomas were of bening nature. However, the fact that in 4 isolated cases there was lymph node involvement indicates that thorough investigation for lymph node metastases is needed, as well as thorough postoperative follow-up.

1.
Burke AP, Helwig EB: Gangliocytic paraganglioma. Am J Clin Pathol 1989;92:1–9.
2.
Inai K, Kobuke T, Yonehara S, Tokuoka S: Duodenal gangliocytic paraganglioma with lymph node metastasis in a 17-year-old boy. Cancer 1989;63:2540–2545.
3.
Perrone T, Sibley RK, Rosai J: Duodenal gangliocytic paraganglioma. An immunohistochemical and ultrastructural study and a hypothesis concerning its origin. Am J Surg Pathol 1985;9:31–41.
4.
Kepes JJ, Zacharias DL: Gangliocytic paragangliomas of the duodenum. A report of two cases with light and electron microscopic examination. Cancer 1971;27:61–70.
5.
Taylor HB, Helwig EB: Benign nonchromaffin paragangliomas of the duodenum. Virchows Arch (A) 1962;335:356–366.
6.
Reed RJ, Daroca PJ Jr, Harkin JC: Gangliocytic paraganglioma. Am J Surg Pathol 1977;1:207–216.
7.
Lukash WM, Hyams VJ, Nielsen OF: Neurogenic neoplasms of the small bowel. Benign nonchromaffin paraganglioma of the duodenum: Report of a case. Am J Dig Dis 1966;11:575–579.
8.
Lauson A, Cadotte M: Paraganglioma ganglicytaire du duodénum. Union Méd Can 1972;101:1584–1586.
9.
Sonneland PR, Scheithauer BW, LeChago J, Crawford BG, Onofrio BM: Paraganglioma of the cauda equina region. Clinicopathologic study of 31 cases with special reference to immunocytology and ultrastructure. Cancer 1986;58:1720–1735.
10.
Kheir SM, Halpern NB: Paraganglioma of the duodenum in association with congenital neurofibromatosis. Possible relationship. Cancer 1984;53:2491–2496.
11.
Stephens M, Williams GT, Jasani B, Williams ED: Synchronous duodenal neuroendocrine tumours in von Recklinghausen’s disease: A case report of co-existing gangliocytic paraganglioma and somatostatin-rich glandular carcinoid. Histopathology 1987;11:1331–1340.
12.
Scheithauer BW, Nora FE, Lechago J, Wick MR, Crawford BG, et al: Duodenal gangliocytic paraganglioma. Clinicopathologic and immunocytochemical study of 11 cases. Am J Clin Pathol 1986;86:559–565.
13.
Aung W, Gallagher HJ et al: Gastrointestinal haemorrhage from a jujunal gangliocytic paraganglioma. J Clin Pathol 1995;48:84–85.
14.
Guarda LA, Ordonez NG, Del Junco GW, Luna MA: Gangliocytic paraganglioma of the duodenum: An immunocytochemical study. Am J Gastroenterol 1983;78:794–798.
15.
Hamid QA, Bishop AE, Rode J, Dhillon AP, et al: Duodenal gangliocytic paragangliomas. A study of 10 cases with immunocytochemical neuroendocrine markers. Hum Pathol 1986;17:1151–1157.
16.
Evans JD, Wilson PG, Barber PC, Neoptolemos JP: Duodenal gangliocytic paraganglioma presenting as an ampullary tumor. Int J Pancreatol 1996;20:131–134.
17.
Gavinell M, Montagnolo G, Tiberio GA, Massari M, Bensi E, Tiberio G: Duodenal gangliocytic paraganglioma: intraoperative ultrasound evaluation. Chir Ital 1998;50:83–86.
18.
Sando WC, Mills SE, Rodgers BM: Duodenal gangliocytic paraganglioma occurring in adolescence. J Pediatr Gastroenterol Nutr 1986;5:659–664.
19.
Buetow PC, Levine MS, Buck JL, Pantongrag-Brown L, Emory TS: Duodenal gangliocytic paraganglioma: CT, MR imaging, and US findings. Radiology 1997;204:745–747.
20.
Dahl EV, Waugh JM, Dahlin DC: Gastrointestinal ganglioneuromas: Brief review with report of a duodenal ganglioneuroma. Am J Pathol 1957;33:953–965.
21.
Büchler M, Malfertheiner P, Baczako K, Krautzberger W, Beger HG: A metastatic endocrine-neurogenic tumor of the ampulla of Vater with multiple endocrine immunoreaction: Malignant paraganglioma? Digestion 1985;31:54–59.
22.
Korbi S, Kapanci Y, Widgren S: Malignant paraganglioma of the duodenum. Immunohistochemical and ultrastructural study of a case. Ann Pathol 1987;7:47–55.
23.
Hashimoto S, Kawasaki S, Matsuzawa K, Harada H, Makuuchi M: Gangliocytic paraganglioma of the papilla of Vater with regional lymph node metastasis. Am J Gastroenterol 1992;87:1216–1218.
24.
Dookhan DB, Miettinen M, Finkel G, Gibas Z: Recurrent duodenal gangliocytic paraganglioma with lymph node metastases. Histopathology 1993;22:399–401.
25.
Barten M, Kloppel G: Gangliocytic paraganglioma of the duodenum. Case report with immunocytochemical characterisation. Zentralbl Allg Pathol 1990;136:181–187.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.